Cargando…

Pulmonary embolism: new treatments for an old problem

Nonvitamin K antagonist oral anticoagulants, previously referred to as novel oral anticoagulants, have emerged in recent years as attractive treatment options for acute pulmonary embolism (PE). However, despite the widespread anticipation by physicians and the approval of rivaroxaban, apixaban, dabi...

Descripción completa

Detalles Bibliográficos
Autor principal: Ryan, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098762/
https://www.ncbi.nlm.nih.gov/pubmed/27843361
http://dx.doi.org/10.2147/OAEM.S103912